[1]
Oğul, A. and Büyükşimşek, M. 2020. Prognostic role of inflammatory markers in hepatocellular cancer patients receiving sorafenib therapy. Medical Science and Discovery. 7, 5 (May 2020), 475–481. DOI:https://doi.org/10.36472/msd.v7i5.374.